Literature DB >> 30919564

Sol-gel technique for the preparation of β-cyclodextrin gold nanoparticles as chiral stationary phase in open-tubular capillary electrochromatography.

Zhen Jiang1, Jialin Qu2, Xiangge Tian3, Xiaokui Huo3, Jianbin Zhang3, Xingjie Guo1, Linlin Fang3.   

Abstract

A novel open-tubular capillary electrochromatography column coated with β-cyclodextrin was prepared using the sol-gel technique. In the sol-gel approach, owing to the three-dimensional network of sol-gel and the strong chemical bond between the stationary phase and the surface of capillary columns, good chromatographic characteristics and unique selectivity in separating enantiomers were shown. The influences of capillary inner diameter, coating time, organic modifier, buffer pH, and buffer concentration on separation were investigated. The sol-gel-coated β-cyclodextrin column has shown improved enantioseparation efficiency of chlorphenamine, brompheniramine, pheniramine, zopiclone in comparison with the sol-gel matrix capillary column. The migration time relative standard deviation of the separation of the enantiomers was less than 0.89% over five runs and 2.9% from column to column. This work confirmed that gold nanoparticles are promising electrochromatographic support to enhance the phase ratio of open-tubular capillary electrochromatography column in capillary electrochromatography.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cyclodextrins; enantiomers; gold nanoparticles; open-tubular capillary electrochromatography; sol-gel processing

Year:  2019        PMID: 30919564     DOI: 10.1002/jssc.201900071

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Gold nanoparticles-functionalized monolithic column for enantioseparation of eight basic chiral drugs by capillary electrochromatography.

Authors:  Mingxuan Ma; Yingxiang Du; Jiangxia Yang; Zijie Feng; Wen Ding; Cheng Chen
Journal:  Mikrochim Acta       Date:  2020-02-19       Impact factor: 5.833

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.